| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/21/2000 | CA2376889A1 Soluble keratin peptide |
| 12/21/2000 | CA2376865A1 Compositions and methods comprising morphine gluconate |
| 12/21/2000 | CA2376523A1 Dna pcv-vaccine |
| 12/21/2000 | CA2376217A1 Novel formulations comprising lipid-regulating agents |
| 12/21/2000 | CA2375576A1 Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 12/21/2000 | CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 12/21/2000 | CA2375346A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy |
| 12/21/2000 | CA2340375A1 Agent for enhancing accumulation of drugs in tumor tissues |
| 12/21/2000 | CA2340120A1 Transdermally delivered aspirin |
| 12/20/2000 | EP1060749A1 Aqueous pharmaceutical composition comprising Tezosentan |
| 12/20/2000 | EP1060743A1 Oral cisapride dosage forms with an extended duration |
| 12/20/2000 | EP1060741A1 Sustained release microspheres |
| 12/20/2000 | EP1060732A2 Novel topical formulations comprising vesicle delivery systems |
| 12/20/2000 | EP1060719A1 Medical pressure-sensitive adhesive tape |
| 12/20/2000 | EP1060667A2 A method to produce pesticide suspension concentrates |
| 12/20/2000 | EP1060011A1 Matrix for preparing microparticles or nanoparticles, method for making said particles and resulting particles |
| 12/20/2000 | EP1060008A1 Method of particle formation |
| 12/20/2000 | EP1059943A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 12/20/2000 | EP1059942A2 Pharmaceutical compositions containing cyclodextrins and taxoids |
| 12/20/2000 | EP1059941A1 Pharmaceutical compositions and their use |
| 12/20/2000 | EP1059939A1 Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 12/20/2000 | EP1059935A1 Mucosal microparticle conjugate vaccine |
| 12/20/2000 | EP1059933A1 Method of increasing bone toughness and stiffness and reducing fractures |
| 12/20/2000 | EP1059928A1 Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 12/20/2000 | EP1059925A1 Ep2-receptor agonists as neuroprotective agents for the eye |
| 12/20/2000 | EP1059920A1 Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis |
| 12/20/2000 | EP1059918A1 Novel dosage form |
| 12/20/2000 | EP1059917A1 Anti-asthma therapy |
| 12/20/2000 | EP1059916A1 Extended release dosage form |
| 12/20/2000 | EP1059915A1 Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 12/20/2000 | EP1059914A2 Method for producing solid, spherical forms containing pharmaceutical active agents in a binder matrix |
| 12/20/2000 | EP1059913A1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 12/20/2000 | EP1059911A1 Formulations with an anti-viral effect |
| 12/20/2000 | EP0879052B1 Preparations stimulating nail growth |
| 12/20/2000 | EP0877555A4 Method of inhibiting immune system destruction of transplanted viable cells |
| 12/20/2000 | EP0844872B1 Use of aromas and flavours to induce or change eating patterns |
| 12/20/2000 | EP0822807B1 Gel with increased oxygen content |
| 12/20/2000 | EP0808154B1 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids |
| 12/20/2000 | EP0800385B1 Oral sustained-release preparation |
| 12/20/2000 | EP0788352B1 Treatment of animals |
| 12/20/2000 | EP0771190A4 Lock and key micelles |
| 12/20/2000 | EP0762875B1 Microparticle delivery system |
| 12/20/2000 | EP0758884B1 Active substance controlled release devices and process for producing the same |
| 12/20/2000 | EP0754030B1 Method for stabilizing duocarmycin derivatives |
| 12/20/2000 | EP0737065B1 Process for preparing solid pharmaceutical dosage forms |
| 12/20/2000 | EP0725624B1 Improvements in and relating to carrier particles for use in dry powder inhalers |
| 12/20/2000 | EP0724428B1 Preparation of medical devices by solid free-form fabrication methods |
| 12/20/2000 | EP0717615B1 Multi-phase compositions for an initial and delayed release of a medicament |
| 12/20/2000 | CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| 12/20/2000 | CN1277555A Composition for improving mental capabilities in mammals |
| 12/20/2000 | CN1277552A Nitric oxide inhibits rhinovirus infection |
| 12/20/2000 | CN1277551A Biphasic lipid vesicle composition for transdermal administration of an immunogen |
| 12/20/2000 | CN1277550A Modified release multiple-units compositions of non-steroid anti-inflammatory drug sbstances (NSAIDS) |
| 12/20/2000 | CN1277549A Vesicular complexes and methods of making and using the same |
| 12/20/2000 | CN1277049A Medicine for treating breast tumor and carbuncle |
| 12/20/2000 | CN1277048A Recipe of medicine for acne and plane warts |
| 12/20/2000 | CN1277036A Ointment to eliminate virulent heat-evil |
| 12/20/2000 | CN1277029A Chewing gum for treating allergic toothache and its preparation |
| 12/20/2000 | CN1277021A Impotence treating medicine spray and its preparation |
| 12/20/2000 | CN1277018A Far infrared plaster and its preparation |
| 12/20/2000 | CN1277017A 乳化混悬制剂 Emulsified suspension formulation |
| 12/20/2000 | CN1277016A Ointment for treating sweety feet and body odor and its preparation |
| 12/20/2000 | CN1059642C 水净化处理装置 Water purification equipment |
| 12/20/2000 | CN1059593C Bony spur pain-relieving plaster and its preparing method |
| 12/20/2000 | CN1059585C A new type scald ointment |
| 12/20/2000 | CN1059583C Chinese herbal medicine oral liquid for deficiency syndrome |
| 12/20/2000 | CN1059582C Traditional Chinese patent drug with function of intensifying intelligence and prolonging life |
| 12/20/2000 | CN1059579C Multiple-effect ointment for treating various surgical diseases |
| 12/20/2000 | CN1059576C Traditional Chinese medicine spray and ointment gauze for treatment of wound |
| 12/20/2000 | CN1059572C Medicine for treating rheumatoid and osteoproliferation and its preparing method |
| 12/20/2000 | CN1059569C Vertigo-relieving tablet and its producing process |
| 12/20/2000 | CN1059558C Bee glue powder and its producing process |
| 12/20/2000 | CN1059555C Preparation for compound sodium fulvate injecta |
| 12/20/2000 | CN1059554C Paper beautifying face mask |
| 12/19/2000 | US6162774 Mixture of salicylic acid, maleic acid and pyruvic acid with detergent base |
| 12/19/2000 | US6162474 Vitamin powders for beverage applications and method of making |
| 12/19/2000 | US6162469 A medical powder comprising a base particle of a ferromagnetic metal having thereon at least one metal oxide layer, and an outside coating containing bioinert polymeric or copolymeric layer and a drug or medical component |
| 12/19/2000 | US6162468 Frozen comestible product provides a tasty, good-textured composition containing nutrients such as vitamins and minerals, flavors, electrolytes, medicine making them more palatable for children |
| 12/19/2000 | US6162467 Sustained release compositions and a method of preparing pharmaceutical compositions |
| 12/19/2000 | US6162466 Sustained release formulation of carbamazepine |
| 12/19/2000 | US6162465 Determining characteristics on dose-level of multiple unit systems, such as dose-level properties relating to the release rate or profile for each indivisually analyzed subunit |
| 12/19/2000 | US6162464 Non-aqueous colonic purgative formulations |
| 12/19/2000 | US6162463 Extended release formulation of diltiazem hydrochloride |
| 12/19/2000 | US6162462 Incubating a bupivacaine solution at a controlled ph which prevents its precipitation, with a suspension of giant multivescular liposomes having greater concentration of ammonium ions inside than outside, removing non-capsulated |
| 12/19/2000 | US6162459 Acyclovir transdermal delivery system |
| 12/19/2000 | US6162456 Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers |
| 12/19/2000 | US6162449 Scleroglucans and cosmetic composition containing the new compounds |
| 12/19/2000 | US6162447 Cosmetic comprising oil phase of given particle size dispersed in aqueous phase comprising given weight percent of a beta-1,3-glucan of given molecular weight range; excludes compositions comprising a surfactant; storage stability |
| 12/19/2000 | US6162444 Cosmetic or pharmaceutical compositions |
| 12/19/2000 | US6162443 Inhalation anesthetic product comprising container constructed from a material containing one or more of polypropylene, polyethylene, and ionomeric resins; with a volume of sevoflurane in the container; storage stability |
| 12/19/2000 | US6162241 Hemostatic tissue sealants |
| 12/19/2000 | US6161536 Dosage form for aerosol administration |
| 12/19/2000 | US6161260 Pharmaceutical tablet designed for easier breaking |
| 12/19/2000 | CA2234826C Fluoxetine enteric pellets |
| 12/19/2000 | CA2184822C Intranasal antimigraine composition |
| 12/19/2000 | CA2174658C Novel composition |
| 12/19/2000 | CA2166970C Seals for use in an aerosol delivery device |
| 12/19/2000 | CA2063791C Hard gelatine capsule containing fat-soluble nutrients. |
| 12/19/2000 | CA2028629C Antiandrogenically-effective pharmaceutical compositions |
| 12/17/2000 | CA2275049A1 Drug delivery composition for dental applications |